Sennosides by New World Imports, Inc / Allegiant Health SENNOSIDES tablet

Sennosides by

Drug Labeling and Warnings

Sennosides by is a Otc medication manufactured, distributed, or labeled by New World Imports, Inc, Allegiant Health. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Sennosides

PURPOSE

Laxative

KEEP OUT OF REACH OF CHILDREN

In case of accidental overdose, contact a doctor or Poison Control Center immediately.

INDICATIONS & USAGE

For relief of occasional constipation and irregularity.

This product produces a bowel movement in 6 to 12 hours.

WARNINGS

Do not use laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor.

Ask a doctor before use if you have a sudden change in bowel habits that persists over a period of 2 weeks.

Ask a doctor or pharmacist before use if you are taking a prescription drug.  Laxatives may affect how other drugs work.  Take this product 2 or more hours before or after other drugs.

When using this product do not use for longer than 1 week unless directed by a doctor

Stop use and ask a doctor if rectal bleeding or failure to have a bowel movement occur after use of a laxative.  These could be signs of a serious condition.

If Pregnant or breast-feeding ask a health professional before use.

DOSAGE & ADMINISTRATION

Take preferably at bedtime or as directed by a doctor.  If you do not have comfortable bowel movement by the second day, increase dose by one tablet (do not exceed the maximum dosage) or decrease dose until you are comfortable.

Adults and children over 12 years: 2 tablets once a day.  Maximum of 4 tablets twice a day.

Children 6 to under 12 years: 1 tablet once a day.  Maximum of 2 tablets twice a day.

Children 2 to under 6 years: 1/2 tablet once a day.  Maximum of 1 tablet twice a day.

Children under 2: consult a doctor

INACTIVE INGREDIENT

Colloidal silicon dioxide, croscarmellose sodium, dibasic dicalcium phosphate dihydrate, lactose, magnesium stearate, microcrystalline cellulose, and tartaric acid.

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

SENNOSIDES 
sennosides tablet

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 51824-217
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
sennosides a and b (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN)	sennosides a and b	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
Croscarmellose Sodium (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
Magnesium stearate (UNII: 70097M6I30)
Cellulose, microcrystalline (UNII: OP1R32D61U)

Product Characteristics
Color	brown (Speckled various shades of brown)	Score	no score
Shape	ROUND (Round)	Size	8mm
Flavor		Imprint Code	AZ;217
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 51824-217-01	100 in 1 BOTTLE; Type 0: Not a Combination Product	09/10/2010	07/01/2020

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	09/10/2010	07/01/2020

Labeler - New World Imports, Inc (075372276)

Establishment
Name	Address	ID/FEI	Business Operations
Allegiant Health		079501930	manufacture(51824-217)